A new study finds breast cancer patients with an inherited genetic mutation don’t always get treatment that follows guidelines.

A new retrospective study addresses the question of how often to screen for breast cancer, suggesting benefits to yearly screening.

Looking beyond DNA mutations to a combination of molecular features could help determine the best drug combinations for each patient.

The finding suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

Up to one-third of primary care providers discussed breast cancer treatment options with patients but many report gaps in their knowledge.